menu
5th International Conference
Advances in Clinical Neuroimmunology
Warsaw, 17-18 June 2016

Final Programme

Friday, 17th June

09:15-10:00
Opening of the Conference
Jacek Losy
10:00-11:30
Session I - Multiple sclerosis I
Chair: Jacek Losy, Zsolt Illes
Individual treatment decisions along benefit-risk estimates of current disease modifying therapies in MS
Thomas Berger (Austria)
Primary progressive MS: immunopathology and new perspectives of therapy
Jacek Losy (Poland)
NEDA as a clinically relevant endpoint for therapeutic decisions
Ron Milo (Israel)
11:30-12:00
Coffee break
12:00-13:30
Session II - Multiple sclerosis II
Chair: Thomas Berger, Ron Milo
Perspectives of the treatment of relapsing-remitting multiple sclerosis
Anna Członkowska (Poland)
Translational omics of de-and remyelination in the CNS
Zsolt Illes (Denmark)
Biomarkers predicting conversion from clinically isolated syndrome to multiple sclerosis
Konrad Rejdak (Poland)
13:30-14:30
Lunch
14:30-16:00
Novartis Satellite session
Chair: Jacek Losy, Przemysław Nowacki
Atrophy and pseudoatrophy in the treatment of MS
Przemysław Nowacki (Poland)
Longterm efficacy data in MS
Őzgür Yaldizli (Switzerland)
The treatment strategies in aggressive multiple sclerosis
Jacek Losy (Poland)
16:00-16:30
Coffee break
16:30-17:30
Short oral presentation Session I
Chair: Anna Członkowska, Konrad Rejdak
Treatment of severe, refractory myasthenia gravis with rituximab
Baruca M.*, Horvat-Ledinek A., Žitnik L., Šega-Jazbec Š.
Neurodegeneration - correlation between tregs, MR spectroscopy and cognitive impairment in relapsing-remitting multiple sclerosis patients
Petrova V.*, Genov K., Mihajlova S., Penkov M.
Understanding the immune microenvironment during neuroinflammation induced by transient cerebral ischemia
Rajan W.D.*, Zawadzka M., Kaminska B.
A case of recurrent anti-NMDA receptor encephalitis
Sipos I.*, Arányi Zs., Bereczki D.
20:00
Banquet (optional)

Saturday, 18th June

09:00-10:30
Session III - Autoimmune neuropathies and myasthenia gravis
Chair: Eduardo Nobile-Orazio, Angela Vincent
Carbohydrate mimicry, Campylobacter jejuni and Guillain-Barré syndrome
Hugh Willison (UK)
Intravenous and subcutaneous immunoglobulin in CIDP and MMN
Eduardo Nobile-Orazio (Italy)
Myasthenia gravis subgroups-clinical, immunological and therapeutic characteristics
Nils Erik Gilhus (Norway)
10:30-11:00
Coffee break
11:00-13:00
Session IV - Neuroimmunological aspects of other neurological disorders
Chair: Amos Korczyn, Brian Weinshenker
Why immunotherapy does not work in AD?
Amos Korczyn (Israel)
Autoimmune encephalitis - diagnosis and therapy
Angela Vincent (UK)
New diagnostic criteria for NMO spectrum disorders
Brian Weinshenker (USA)
Central nervous system vasculitis - immunopathology and therapy
Przemysław Nowacki (Poland)
13:00-14:00
Lunch
14:00-15:00
Session V - Multiple sclerosis and other neurological disorders
Chair: Paul Matthews, Jacek Losy
MRI for medicine safety and efficacy monitoring in MS
Paul Matthews (UK)
Neuroimmunology of ALS
Andrea Malaspina (UK)
15:00-15:15
Coffee break
15:15-17:00
Short oral presentation Session II
Chair: Andrea Malaspina, Thomas Berger
Aquaporin-4 antibody-positive longitudinally extensive transverse myelitis in a patient with ankylosing spondylitis - report of the first case
Karlinska A.*, Blażejewska-Hyzorek B., Kurkowska-Jastrzębska I.
Changes of the cell body of neurons in central nerve system and behavioral change in mice at model of demyelination and remyelination
Melnyk N.*, Labunets I., Rymar S.
Heat shock protein 70 and lysosomal-associated membrane protein 2A expression in peripheral blood mononuclear cells and cognitive functions in lung cancer patients
Rybacka-Mossakowska J., Michalak S., Gazdulska J., Gołda-Gocka I., Ramlau R.
Neonatal BCG Vaccination Potentiates Neurogenesis and Spatial Cognition Caused by Enriched Environment via a shift in meningeal macrophage-M2 polarization
Qi F.*, Jie Z., Yang J., Xing Z., Yuan Q.-F., Zou J., Guo K., Yao Z.
Neonatal HBV Vaccination followed by LPS challenge induce autism-like behavior in mice
Wang X., Yao Z.*
GCase report: Myasthenia gravis and/or multiple sclerosis,could it be MELAS?
Butkoviċ Soldo S., Miśeviċ S., Soldo Koruga, Perkoviċ R.
The prognostic value of anti-neural antibodies in gynecological cancers
Walerych M.*, Wójcicka K., Dyzmann-Sroka A., Trojanowski M., Sajdak S.
17:00
Concluding remarks
Jacek Losy
updated: 2016-06-27